medigraphic.com
SPANISH

Revista Mexicana de Neurociencia

Academia Mexicana de Neurología, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 1

<< Back Next >>

Rev Mex Neuroci 2013; 14 (1)

Neurological complications of the influenza AH1N1 virus infection in Mexico

González-Duarte A, Soto-Cárdenas K
Full text How to cite this article

Language: Spanish
References: 20
Page: 17-20
PDF size: 208.93 Kb.


Key words:

Complications, influenza A(H1N1), encephalopathy, outcome.

ABSTRACT

Background: Influenza A(H1N1) infection has been associated with neurological complications, specially in children, although its frequency or the factors that influence its occurrence are unknown. Objectives: To describe the neurologic complications of influenza A(H1N1) infection in a cohort of Mexican adults. Diagnosis was achieved through PCR testing for A(H1N1) in a nasal exudate. Methods: This is a prospective study performed from January 2010 up to April 2012. All neurological signs and symptoms were documented form the beginning of the disease and through all the hospital stay. Results: A total of 118 patients were analyzed with a mean age of 47 ± 18 years. Thirteen cases (11%) had a previous history of neurological disease, but did not show further SNC complications. The most common neurologic manifestation was headache, which occurred in 63(53%) of the cases. Fifteen cases (12%) had diffuse encephalopathy, characterized by headache, sleepiness and dysautonomia. Three cases (2.5%) had neurological sequelae, parkinsonian tremor and muscle rigidity in two and behavioral changes in one. Conclusion: The influenza A(H1N1) infection in adults was associated with diffuse encephalopathy in 12% of the cases. Fortunately, its course was benign, as only 2.5% of the cases presented neurological sequelae.


REFERENCES

  1. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362; 1708-19.

  2. Navarro-Marí JM, Mayoral-Cortés JM, Pérez-Ruiz M, et al. Influenza A(H1N1) virus infection in humans: review to 30th October 2009. Emerg Infecc Microbiol Clin 2010; 28(7): 446-52.

  3. Ekstrand JJ, Herbener J, Rawlings J et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol 2010; 68: 762-6.

  4. Chen YC, Lo CP, Chang TP. Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features: a case report. J Neurol Sci 2010; 298: 110-11.

  5. Ng WF, Chiu SC, Lam DS, et al. A 7-year-old boy dying of acute encephalopathy. Brain Pathol 2010; 20: 261-4.

  6. Ozdemir H, Karbuz A, Ciffci E, et al. Aseptic meningitis in a child due to2009 pandemic influenza A (H1N1) infection. Turk J Pediatric 2011; 53(1): 91-3.

  7. Spalice A, Del Balzo F, Nicita F, et al. Teaching Neuroimages: Acute necrotizing encephalopathy during novel influenza A (H1N1) virus infection. Neurology 2011; 77(21): 3121.

  8. Kahle KT, Walcott BP, Nahed BV, et al. Cerebral edema and a transtentorial brain herniation syndrome associated with pandemic swine influenza A (H1N1) virus infection. J Clin Neurosci 2011; 18(9): 1245-8.

  9. Ito S, Sima S, Ueda A, et al. Transient Splenial Lesion of the Corpus Callosum in H1N1 Influenza virus-Associated Encephalitis/Encephalopathy. Intern Med 2011; 50: 915-18.

  10. Chistensen PS, Pedersen BB, Gulisano H, et al. Cerebral manifestations of influenza A (H1N1)v. Ugeskr Laeger 2010; 29(48); 2245-6.

  11. Buccoliero G, Romanelli C, Lonero G, et al. Encephalitis associated to novel influenza A virus infection (H1N1) in two young adults. Recenti Prog Med 2010; 101(7-8): 307.

  12. González-Duarte A, Magaña Zamora L, Cantú-Brito C, García Ramos G. Hypothalamic abnormalities and Parkinism associated with H1N1 influenza infection. J Neurinflammation 2012; 7: 47.

  13. Hasegawa S, Matsushiage T, Inoue H, et al. Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virusassociated encephalopathy. Cytokine 2011; 54(2): 167-72.

  14. Moore G. Influenza and Parkinson´s disease. Public Health Rep 1977; 92(1): 79-80.

  15. Poskanzer D, Schwab R. Studies in the epidemiology of Parkinson´s disease predicting its disappearance as a major clinical entitity by 1980. Trans Am Neurol Assoc 1961; 86: 234-5.

  16. Brown E, Knox E. Epidemiology approach to Parkinson’s disease. Lancet 1972; 974-6.

  17. Kaplan S. Age distribution of patients with Parkinson’s disease in 1960 and 1970 in 110 hospitals. Neurology 1974; 24; 972-5.

  18. Leibowitz U, Feldman S. Age shift in parkinsonism. Isr J Med Sci 1973; 9: 599-602.

  19. Kessler I. Epidemiologic studies of Parkinson’s diseaes. A comunity based survey. Am J Epidemiolo 1972; 96: 242-53.

  20. Bal A, Suri V, Mishra B, et al. Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009-2010. Histopathology 2012; 60(2): 326-35.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Neuroci. 2013;14